Position in INCY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,964,780
+$475,776 QoQ
Shares Held
31,500
+25.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HUSSMAN STRATEGIC ADVISORS, INC. holds $44,137,764 across 23 Biotechnology names. INCY ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
126,000 | $5,079,060 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
168,000 | $3,739,680 | |
| 3 | INVA |
Innoviva, Inc.
|
147,000 | $3,425,100 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
52,500 | $3,393,075 | |
| 5 | INCY |
Incyte Corp
This page
|
31,500 | $2,964,780 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
84,000 | $2,735,040 | |
| 7 | SEPN |
Septerna, Inc.
|
105,000 | $2,523,150 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
84,000 | $2,352,840 |
All Filings in INCY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,964,780 | 31,500 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,489,004 | 25,200 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,671,515 | 31,500 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $4,290,300 | 63,000 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,178,875 | 52,500 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,900,940 | 42,000 | Shares | Sole | 2025-02-03 | |
| 2024-06-30 | $1,909,530 | 31,500 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,794,555 | 31,500 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,977,885 | 31,500 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $2,253,030 | 39,000 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,427,750 | 39,000 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $3,360,555 | 46,500 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,734,880 | 46,500 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,065,840 | 31,000 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $706,521 | 9,300 | Shares | Sole | 2022-09-12 | |
| No filing history on record for this holder in this stock. | ||||||